HotSheets by Year

2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001

HotSheets 2008

January February March April May June July August September October November December

January | Newsletter

Overall Survival Analysis of SPARC Trial
Patients Often Get Contraindicated Therapy
Us TOO’s 2008 Board Members/Officers
Post-Prostatectomy Incontinence Treatment
Letter to the Editor
Doc Moyad’s What Works and What is Worthless Column—Statins
Read more..

February | Newsletter

Senate Passes Last-Minute ‘Rescue” for Doctors Facing Big Medicare Cuts
Aspirin Impairs Prostate Cancer Treatment
More FDA Action Possible for ESAs
Cancer Tool Shows Promise in Scottsdale
Hormones Delay Prostate Cancer Growth
Research Yields Clues to Cancer Recurrence
Read more..

March | Newsletter

Supreme Court Declines Review in the Abigail Alliance Experimental Drug Case
Editorial: Provenge Pressure Builds on FDA
Cell Genesys’ Clinical Trials to Continue
Supreme Court Sides with Washington University in Tissue Ownership Case
No Link Between Androgen and Risk for PCa
Us TOO Raises Minority Cancer Awareness
Read more..

April | Newsletter

Special Burning Issues Supplement: Highlights from ASCO’s 2008 Genitourinary Cancers Symposium—San Francisco, CA, February 14-16, 2008
New Analysis Out on Cancer Drug
GTx’s Toremifene Meets Primary Endpoints
Treatment Decision-Making Not Easy
The Power of Words for Cancer Patients
April Brings a New Look to SEA Blue for National Minority Cancer Awareness Week
Genetic Variants Found to be Associated with Prostate Cancer
Read more..

May | Newsletter

Doctors Use “GPS for the Body” to Target Cancer Cells
Takeda, Cell Genesys Partner to Develop Prostate Cancer Vaccine
Blood Test Indicates Nodal Spread in Localized Prostate Cancer
Medicare Changes Influenced Prostate Cancer Treatment Decisions
New Information Drives Changes in Bladder Control Treatment
Outer–Course vs. Inter-Course
Geneve Bio Developing Revolutionary Curative ED Treatment
Read more..

June | Newsletter

Experimental Vaccine Shows Promise in Prostate Cancer
Celebrex-Lipitor Combination May Halt Prostate Cancer
Prostate Cancer Mortality Declining Faster in the United States than in Britain
Iowa, Arizona Expand on SEA Blue African American Awareness Campaign
Similar Survival with Salvage Surgery (RP) and Radiotherapy (RT)
Gene Activity and Cancer’s Racial Divide
Nanotechnology Enhances Early Detection of Prostate Cancer in Black Males
Read more..

July | Newsletter

New Analysis Boost’s Finasteride’s Value
Active Surveillance Still a Viable Option
Adjuvant Radiation Shows Promise for High-Risk Surgery Patients
Kennedy Has Major Cancer Bill in Senate
Prostate Cancer Vaccine Linked to Improved Survival in Small Trial
Amgen Reports Positive Data at ASCO for Denosumab in Cancer Patients
‘Equivocal’ Antioxidant Effects in Cancer Therapy
Read more..

August | Newsletter

Pints for Prostates Delivers Men’s Health Message
Mrs. Illinois 2008 Supports Prostate Cancer Awareness and Us TOO International
Proscar® Lowers Prostate Cancer Risk in All Men
Radiation May Help After Prostate Cancer Setback
GPC Biotech Announces NCI-Sponsored Phase 2 Trial of Satraplatin in Metastatic HRPC
Doc Moyad’s “What Works and What Is Worthless Column”—Saturated Fat
Read more..

September | Newsletter

Prostate Test Advice for Elderly Won’t Stop Debate
First Annual Edward C. Kaps Hope Award Winners Announced
Amgen Announces Positive Results for Denosumab
Do You Know Where Your Prostate Cancer Tissue Is?
Early Findings Create Buzz for Potent Novel Hormone Blocker
Us TOO Seeks Board Member Nominations
Read more..

October | Newsletter

Cell Genesys Halts GVAX Trial
The Wrong Call on Prostate Cancer Screening
Blood Calcium Tied to Lethal Prostate Cancer
Researchers Find Prostate Cancer Gene
Regular NSAID Use May Reduce PSA Levels
2nd Annual Cancer Awareness Days in NJ
Doc Moyad’s "What Works and What Is Worthless Column"— I.V. Vitamin C
Read more..

November | Newsletter

Radiation Added to Androgen Deprivation Therapy Halves Risk of Prostate Cancer Death
Dendreon Announces Interim Data from Phase 3 Provenge IMPACT Trial
Novacea Has No Plans to Develop Asentar®
Understanding Scientific Studies & Reports – Determining What’s Good & What’s Not
The Patient as Healer – How to Alleviate Your Pain and Stress
Proton Radiation Fails to Impress in Prostate Cancer Study
Read more..

December | Newsletter

Cell Genesis Announces Termination of Phase 3 VITAL-1 GVAX Clinical Trial
Vitamin E and Selenium Do Not Prevent Prostate Cancer: Large-Scale Study Stopped
AUA Best Practice Statement Recommends Cryosurgery in Certain Prostate Cancer
Rethinking Prostate Cancer in Older Men
Prostate Cancer Awareness Events: Greater Chicago Prostate Cancer Run Walk ‘n Roll
Lawyer, Mountain Climber Names Us TOO As Beneficiary
Read more..